<DOC>
	<DOCNO>NCT00485849</DOCNO>
	<brief_summary>The primary purpose study evaluate tolerability effectiveness atomoxetine treatment attention problem , hyperactivity , impulsivity child ASD , secondarily , evaluate possible response atomoxetine core symptom ASD</brief_summary>
	<brief_title>A Study Atomoxetine Attention Deficit Hyperactive/Impulsive Behaviour Problems Children With ASD</brief_title>
	<detailed_description />
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Problem Behavior</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Impulsive Behavior</mesh_term>
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<criteria>Male female outpatient age least 6 year age 17 year age visit 1 Autistic Spectrum Disorder ( DSMIV TR ) diagnosis Autistic disorder Asperger syndrome PDDNOS Clinically significant symptom ADHD ( i.e . inattention , impulsiveness , hyperactivity ) present least six month ( subject older 8 year , onset symptom must age 7 year ) Medicationfree least two week psychotropic medication ( four week fluoxetine depotneuroleptics ) Patients must also able swallow capsule Patients weigh less 20 kg great 60 kg visit 2 DSMIV TR diagnosis Pervasive Developmental Disorder Autistic Disorder , PDDNOS , Asperger 's Disorder ( e.g . Rett 's Disorder , Childhood Disintegrative Disorder ) Patients history Bipolar I II disorder , schizophrenia , psychosis Patients current diagnosis Major Depression ( without psychotic feature ) , PTSD Patients history seizure disorder ( febrile seizure ) patient take ( currently take ) anticonvulsant seizure control</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>June 2007</verification_date>
</DOC>